← Open Payments lookup

LESLIE WOLF: Open Payments

NPI 1235354572 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,228 in 51 payments from 14 companies in 2025. Trend: 2023 $855 · 2024 $1,518 · 2025 $1,228

Food & beverage: $1,228
CompanyPaymentsAmount
Madrigal Pharmaceuticals13$360
Lilly USA, LLC1$122
Gilead Sciences, Inc.4$116
Regeneron Healthcare Solutions, Inc.4$96
Janssen Biotech, Inc.5$96
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$86
GENZYME CORPORATION3$86
ABBVIE INC.4$82
Takeda Pharmaceuticals U.S.A., Inc.2$44
Phathom Pharmaceuticals, Inc.5$42

Products named: REZDIFFRA, DUPIXENT, OMVOH, TREMFYA, XIFAXAN, VOQUEZNA, IQIRVO, RINVOQ.

Industry payments across NE — which companies pay providers there.